0.39
0.00%
0.00
시간 외 거래:
.39
Seelos Therapeutics Inc (SEEL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
11.33%
0.579
|
0.653 | 0.406 | 0.336 | 0.808 |
Operating Expenses
|
23.43%
6.634
|
8.664 | 13.01 | 11.29 | 9.74 |
Interest Income/Expense |
21.05%
0.023
|
0.019 | 0.042 | 0.007 | 0.007 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
23.43%
6.634
|
8.664 | 13.01 | 11.29 | 9.74 |
Operating Income/Loss |
24.42%
-6.055
|
-8.011 | -12.60 | -10.95 | -8.932 |
Nonoperating Income/Loss |
32.56%
3.391
|
2.558 | 23.10 | -18.54 | -4.499 |
Income/Loss From Continuing Operations Before Tax |
11.33%
0.579
|
0.653 | 0.406 | 10.50 | 0.808 |
Income/Loss From Continuing Operations After Tax |
51.15%
-2.664
|
-5.453 | 10.50 | 10.50 | -13.43 |
Net Income/Loss
|
51.15%
-2.664
|
-5.453 | 10.50 | 10.50 | -13.43 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
110.68%
13.01
|
-121.77 | 135.33 | 131.92 | 112.52 |
Diluted Average Shares |
110.68%
13.01
|
-121.77 | 148.14 | 131.92 | 112.52 |
Basic Earnings Per Share |
97.32%
-0.20
|
-7.47 | 0.08 | -0.22 | -0.12 |
Diluted Earnings Per Share |
97.32%
-0.20
|
-7.47 | -0.12 | -0.22 | -0.12 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):